- Home
- SD vs FLGT Comparison
SD vs FLGT Comparison
Compare SD & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SD
- FLGT
- Stock Information
- Founded
- SD 2006
- FLGT 2011
- Country
- SD United States
- FLGT United States
- Employees
- SD N/A
- FLGT N/A
- Industry
- SD Oil & Gas Production
- FLGT Medical Specialities
- Sector
- SD Energy
- FLGT Health Care
- Exchange
- SD Nasdaq
- FLGT Nasdaq
- Market Cap
- SD 465.2M
- FLGT 508.7M
- IPO Year
- SD 2007
- FLGT 2016
- Fundamental
- Price
- SD $12.21
- FLGT $16.46
- Analyst Decision
- SD
- FLGT Hold
- Analyst Count
- SD 0
- FLGT 1
- Target Price
- SD N/A
- FLGT $22.00
- AVG Volume (30 Days)
- SD 221.1K
- FLGT 225.7K
- Earning Date
- SD 03-05-2025
- FLGT 02-28-2025
- Dividend Yield
- SD 3.60%
- FLGT N/A
- EPS Growth
- SD N/A
- FLGT N/A
- EPS
- SD 1.27
- FLGT N/A
- Revenue
- SD $120,243,000.00
- FLGT $277,761,000.00
- Revenue This Year
- SD N/A
- FLGT N/A
- Revenue Next Year
- SD $43.19
- FLGT $16.00
- P/E Ratio
- SD $9.61
- FLGT N/A
- Revenue Growth
- SD N/A
- FLGT N/A
- 52 Week Low
- SD $10.31
- FLGT $15.99
- 52 Week High
- SD $15.31
- FLGT $25.50
- Technical
- Relative Strength Index (RSI)
- SD 52.32
- FLGT 42.71
- Support Level
- SD $11.95
- FLGT $16.47
- Resistance Level
- SD $12.59
- FLGT $17.39
- Average True Range (ATR)
- SD 0.30
- FLGT 0.54
- MACD
- SD 0.01
- FLGT 0.10
- Stochastic Oscillator
- SD 59.47
- FLGT 33.57
About SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services.
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.